247 related articles for article (PubMed ID: 1397748)
1. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Creutzfeldt W; Lamberts R
Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
[TBL] [Abstract][Full Text] [Related]
2. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment.
Solcia E; Fiocca R; Havu N; Dalväg A; Carlsson R
Digestion; 1992; 51 Suppl 1():82-92. PubMed ID: 1397749
[TBL] [Abstract][Full Text] [Related]
3. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P
Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
[TBL] [Abstract][Full Text] [Related]
6. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
[TBL] [Abstract][Full Text] [Related]
7. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
Hage E; Hendel L; Gustafsen J; Hendel J
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
[TBL] [Abstract][Full Text] [Related]
8. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
Lamberts R; Creutzfeldt W; Strüber HG; Brunner G; Solcia E
Gastroenterology; 1993 May; 104(5):1356-70. PubMed ID: 8482449
[TBL] [Abstract][Full Text] [Related]
9. Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis.
Bordi C; Pilato F; Carfagna G; Ferrari C; D'Adda T; Sivelli R; Bertelé A; Missale G
Digestion; 1986; 35 Suppl 1():130-43. PubMed ID: 3792670
[TBL] [Abstract][Full Text] [Related]
10. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa.
Borch K; Renvall H; Liedberg G; Andersen BN
Scand J Gastroenterol; 1986 Apr; 21(3):357-63. PubMed ID: 3715400
[TBL] [Abstract][Full Text] [Related]
11. Fundic argyrophil cell hyperplasia in atrophic gastritis: a search for a sensitive diagnostic method.
Belaiche J; Delwaide J; Vivario M; Gast P; Louis E; Boniver J
Acta Gastroenterol Belg; 1993; 56(1):11-7. PubMed ID: 7688175
[TBL] [Abstract][Full Text] [Related]
12. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.
Solcia E; Rindi G; Havu N; Elm G
Scand J Gastroenterol Suppl; 1989; 166():129-37; discussion 138-9. PubMed ID: 2513643
[TBL] [Abstract][Full Text] [Related]
13. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
Creutzfeldt W; Lamberts R; Stöckmann F; Brunner G
Scand J Gastroenterol Suppl; 1989; 166():122-8; discussion 138-9. PubMed ID: 2513642
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
15. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
Lehy T; Roucayrol AM; Mignon M
Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
[TBL] [Abstract][Full Text] [Related]
16. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
Bardram L; Thomsen P; Stadil F
Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Rindi G; Fiocca R; Morocutti A; Jacobs A; Miller N; Thjodleifsson B;
Eur J Gastroenterol Hepatol; 2005 May; 17(5):559-66. PubMed ID: 15827447
[TBL] [Abstract][Full Text] [Related]
18. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
Eissele R; Brunner G; Simon B; Solcia E; Arnold R
Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
[TBL] [Abstract][Full Text] [Related]
19. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
[TBL] [Abstract][Full Text] [Related]
20. Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.
Havu N; Maaroos HI; Sipponen P
Scand J Gastroenterol Suppl; 1991; 186():90-4. PubMed ID: 1759136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
